Cargando…
Gene Expression and Protein Abundance of Nuclear Receptors in Human Intestine and Liver: A New Application for Mass Spectrometry-Based Targeted Proteomics
Background: Unwanted drug-drug interactions (DDIs), as caused by the upregulation of clinically relevant drug metabolizing enzymes and transporter proteins in intestine and liver, have the potential to threaten the therapeutic efficacy and safety of drugs. The molecular mechanism of this undesired b...
Autores principales: | Wenzel, Christoph, Gödtke, Lisa, Reichstein, Anne, Keiser, Markus, Busch, Diana, Drozdzik, Marek, Oswald, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318449/ https://www.ncbi.nlm.nih.gov/pubmed/35889510 http://dx.doi.org/10.3390/molecules27144629 |
Ejemplares similares
-
Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
por: Wenzel, Christoph, et al.
Publicado: (2021) -
Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
por: Klomp, Florian, et al.
Publicado: (2020) -
Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach
por: Lapczuk-Romanska, Joanna, et al.
Publicado: (2019) -
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021) -
Protein Abundance of Drug Transporters in Human Hepatitis C Livers
por: Droździk, Marek, et al.
Publicado: (2022)